SPONSOR
Montreal Heart Institute
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Conditions studied: Platelet AggregationType 2 DiabetesAspirinDiabetes Mellitus, Type 2Platelet Aggregation InhibitorsLeft Bundle-Branch BlockAortic Valve StenosisRight Heart FailureRight Ventricular Dysfunction
Montreal Heart Institute is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Platelet Aggregation, Type 2 Diabetes, Aspirin, Diabetes Mellitus, Type 2.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Montreal Heart Institute
How many clinical trials has Montreal Heart Institute sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Montreal Heart Institute, of which 3 are actively recruiting participants. These trials cover conditions including Platelet Aggregation, Type 2 Diabetes, Aspirin. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Montreal Heart Institute research focus on?
Montreal Heart Institute clinical trials span Platelet Aggregation, Type 2 Diabetes, Aspirin, Diabetes Mellitus, Type 2, Platelet Aggregation Inhibitors, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Montreal Heart Institute clinical trial?
To participate in a Montreal Heart Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Montreal Heart Institute trials with current recruitment status updated daily.
Clinical Trials by Montreal Heart Institute
NCT05702463 Phase 1
Recruiting
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
Platelet Aggregation
NCT03303612
Recruiting
Clinical Monitoring Strategy Versus Electrophysiology-guided Algorithmic Approach With a New LBBB After TAVI
Left Bundle-Branch Block
NCT05450328 Phase 2
Recruiting
Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation
Right Heart Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology